Melatonin prevents diabetes-induced nephropathy by modulating the AMPK/SIRT1 axis: Focus on autophagy and

Jain Siddhi1, Bhoomika Sherkhane1, Anil Kumar Kalavala2

  • 1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Balanagar, India.

Cell Biology International
|September 10, 2022
PubMed

Insights

Melatonin protects against diabetic kidney disease by enhancing nutrient sensing pathways like AMPK/SIRT1 and autophagy. This study shows melatonin improves kidney function and cellular health in diabetic models.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cell Biology

Background:

  • Diabetic kidney disease involves impaired nutrient sensing (AMPK/SIRT1) and autophagy.
  • Melatonin, an antioxidant, may modulate these pathways.
  • Targeting these mechanisms could prevent renal damage.

Purpose of the Study:

  • To investigate melatonin's protective effects against diabetic renal injury.
  • To assess melatonin's impact on AMPK/SIRT1 axis and autophagy in diabetic nephropathy.
  • To elucidate the role of AMPK activation in melatonin's renoprotective action.

Main Methods:

  • Streptozotocin-induced diabetic nephropathy model in rats.
  • In vitro high-glucose-induced tubular injury model using NRK-52E cells.
  • Melatonin administration and AMPK inhibition (Compound-C) followed by molecular analysis.

Main Results:

  • Melatonin treatment improved renal function and attenuated injury in diabetic rats.
  • Melatonin upregulated AMPK, SIRT1, PGC-1α, TFAM, and enhanced autophagy in vivo and in vitro.
  • Inhibition of AMPK reversed melatonin's protective effects in NRK-52E cells.

Conclusions:

  • Melatonin exerts renoprotective effects in diabetic nephropathy.
  • These effects are mediated by the upregulation of the AMPK/SIRT1 axis, autophagy, and mitochondrial health.
  • Melatonin shows therapeutic potential for managing diabetic kidney disease.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
313
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
664